DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment

 

Oncology Homepage

Baptist Hospital's Miami Cancer Institute awarded cancer research and education grant by IBA

ASCO expands TAPUR study enrollment after promising initial treatment outcomes seen

Delta4 Discover transmission detector approved for use by Varian Medical Systems on TrueBeam and Clinac systems

Intraoperative imaging systems market to reach $3.4 billion by 2024

Varian to showcase technologies for enhancing oncology care coordination at AONN+ Conference

United States proton therapy market is expected to reach nearly $1 billion, potentially $7 billion by 2025

Critical prostate cancer research funding saved

iCAD's Xoft clinical research selected as 'Best of ASTRO 2017'

Biop Medical launches cervical cancer diagnosis tech at Medica

Leading Belgian hospital OLVZ selects RayStation

SCOUT radar localization system demonstrated at Lynn Sage Breast Cancer Symposium

Press releases may be edited for formatting or style
ALISO VIEJO, CALIF., 14 September 2017 – Cianna Medical, Inc., today announced that its next-generation SCOUT radar localization system featuring real-time distance measurement will be exhibited for the first time at the Lynn Sage Breast Cancer Symposium in Chicago, IL, September 14-17, 2017.

The next-generation SCOUT technology advances the power of RADAR for breast tumor localization, making it the most precise and broadly applicable localizing system in the industry. It is clinically proven to be both consistent and predicable, and both physicians and patients will benefit from its unprecedented 60 mm range and 360˚ signal detection with +/- 1 mm accuracy. The real-time distance measurement and instant signal response will make it easier for surgeons to locate non-palpable tumors during breast surgery.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your transducer with the same precision and care you provide to your patients. Now offering TotalREPAIR on 140 transducer models! Call us at 1-844-5100 or visit www.mvs.bayer.com to set up an order today.



SCOUT, an FDA-cleared localization system, is the world’s only technology that utilizes radar in human tissue, and it is changing the standard of care for breast tumor localization. Previously published data established SCOUT as an accurate and reliable method to localize and excise breast lesions. SCOUT has been quickly adopted at over 150 leading medical facilities across the United States, and it has been used in more than 16,000 patient procedures to date.

Alice Police, M.D., breast surgeon, University of California, Irvine, recently completed validation of the next-generation SCOUT system that will measure and display distance in millimeters. “SCOUT is the standard of care for all my breast lesion localizations. The distance feature provides more control over the procedure, which is important for predictable outcomes,” Dr. Police stated.

The Lynn Sage Breast Cancer Symposium is a multidisciplinary event that brings together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer.

About SCOUT
The FDA-cleared SCOUT system features a proprietary, highly sophisticated reflector that is precisely placed at the tumor site up to 30 days before a lumpectomy or surgical biopsy. During the procedure, the surgeon scans the breast using the SCOUT guide which emits 50 million pulses per second, allowing the surgeon to “lock” in on the reflector’s precise location with ± 1mm of accuracy. This higher level of localization precision allows better surgical planning that may improve cosmetic results, as less tissue may need to be removed. SCOUT has an exceptional detection range of 1mm – 60mm, documented migration of <2% across multiple studies, and is OR compatible.

• Cianna Medical

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED